Evaluation of intravenous magnesium sulphate in clinical imrovement of patients, with acute stroke, in Ardabil Alavi hospital
Phase 2
- Conditions
- Stroke.Accident - vascular, brain
- Registration Number
- IRCT2014060117945N1
- Lead Sponsor
- Ardabil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Age greater than 18 years old; Age less than 80 years old; onset of symptoms less than 12 hour .
Exclusion criteria: : Patient with chronic renal failure (more than 5.2); pregnant patients; patients with brain hemorrhage; age less than 18 years old; systolic blood pressure greater than 220 and diastolic lower than 90; patient with severe respiratory disease; patient with heart block; Patients with pre-existing neurological disease or progressive systemic disease that can impair neurological assessment.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Degree of limb paresis. Timepoint: Admission - three days later - two weeks later. Method of measurement: Standard questionnaire NIHSS.;Aphasia. Timepoint: Admission - three days later - two weeks later. Method of measurement: Standard questionnaire NIHSS.;Level of consciousness. Timepoint: Admission - three days later - two weeks later. Method of measurement: Standard questionnaire NIHSS.
- Secondary Outcome Measures
Name Time Method The rate of cerebral ischemia. Timepoint: 3 day later - 2 week later. Method of measurement: CT-scan.